ruxolitinib 10 mg (TABLET)
|
$69.9728
|
|
AUS PBS
|
generic
|
Jakavi (56) |
Novartis Pharmaceuticals Australia Pty Limited |
|
ruxolitinib 10 mg (TABLET)
|
$158.2242
|
|
VA Big4
|
|
JAKAFI (60) |
Incyte Corporation |
|
ruxolitinib 10 mg (TABLET)
|
$225.6322
|
|
VA FSS
|
|
JAKAFI (60) |
Incyte Corporation |
|
ruxolitinib 15 mg (TABLET)
|
$69.9728
|
|
AUS PBS
|
generic
|
Jakavi (56) |
Novartis Pharmaceuticals Australia Pty Limited |
|
ruxolitinib 15 mg (TABLET)
|
$158.7158
|
|
VA Big4
|
|
JAKAFI (60) |
Incyte Corporation |
|
ruxolitinib 15 mg (TABLET)
|
$225.6322
|
|
VA FSS
|
|
JAKAFI (60) |
Incyte Corporation |
|
ruxolitinib 20 mg (TABLET)
|
$69.9728
|
|
AUS PBS
|
generic
|
Jakavi (56) |
Novartis Pharmaceuticals Australia Pty Limited |
|
ruxolitinib 20 mg (TABLET)
|
$158.3142
|
|
VA Big4
|
|
JAKAFI (60) |
Incyte Corporation |
|
ruxolitinib 20 mg (TABLET)
|
$225.6322
|
|
VA FSS
|
|
JAKAFI (60) |
Incyte Corporation |
|
ruxolitinib 25 mg (TABLET)
|
$159.0205
|
|
VA Big4
|
|
JAKAFI (60) |
Incyte Corporation |
|
ruxolitinib 25 mg (TABLET)
|
$225.6322
|
|
VA FSS
|
|
JAKAFI (60) |
Incyte Corporation |
|
ruxolitinib 5 mg (TABLET)
|
$34.9864
|
|
AUS PBS
|
generic
|
Jakavi (56) |
Novartis Pharmaceuticals Australia Pty Limited |
|
ruxolitinib 5 mg (TABLET)
|
$158.9427
|
|
VA Big4
|
|
JAKAFI (60) |
Incyte Corporation |
|
ruxolitinib 5 mg (TABLET)
|
$225.6322
|
|
VA FSS
|
|
JAKAFI (60) |
Incyte Corporation |
|